Cargando…
Peptide density targets and impedes triple negative breast cancer metastasis
The C-X-C chemokine receptor type 4 (CXCR4, CD184) pathway is a key regulator of cancer metastasis. Existing therapeutics that block CXCR4 signaling are dependent on single molecule-receptor interactions or silencing CXCR4 expression. CXCR4 localizes in lipid rafts and forms dimers therefore CXCR4 t...
Autores principales: | Liu, Daxing, Guo, Peng, McCarthy, Craig, Wang, Biran, Tao, Yu, Auguste, Debra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031661/ https://www.ncbi.nlm.nih.gov/pubmed/29973594 http://dx.doi.org/10.1038/s41467-018-05035-5 |
Ejemplares similares
-
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
por: Guo, Peng, et al.
Publicado: (2019) -
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
por: Guo, Peng, et al.
Publicado: (2016) -
Nanoparticle elasticity directs tumor uptake
por: Guo, Peng, et al.
Publicado: (2018) -
The development of activatable lytic peptides for targeting triple negative breast cancer
por: Zhao, Hui, et al.
Publicado: (2017) -
Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
por: Neophytou, Christiana, et al.
Publicado: (2018)